These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 9934484
1. Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors. Baker CT, Salituro FG, Court JJ, Deininger DD, Kim EE, Li B, Novak PM, Rao BG, Pazhanisamy S, Schairer WC, Tung RD. Bioorg Med Chem Lett; 1998 Dec 15; 8(24):3631-6. PubMed ID: 9934484 [Abstract] [Full Text] [Related]
2. Design and synthesis of novel conformationally restricted HIV protease inhibitors. Salituro FG, Baker CT, Court JJ, Deininger DD, Kim EE, Li B, Novak PM, Rao BG, Pazhanisamy S, Porter MD, Schairer WC, Tung RD. Bioorg Med Chem Lett; 1998 Dec 15; 8(24):3637-42. PubMed ID: 9934485 [Abstract] [Full Text] [Related]
4. Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands. Zhu M, Du XN, Li YG, Zhang GN, Wang JX, Wang YC. Bioorg Med Chem Lett; 2019 Feb 01; 29(3):357-361. PubMed ID: 30580917 [Abstract] [Full Text] [Related]
6. HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope. Rusere LN, Lockbaum GJ, Lee SK, Henes M, Kosovrasti K, Spielvogel E, Nalivaika EA, Swanstrom R, Yilmaz NK, Schiffer CA, Ali A. J Med Chem; 2019 Sep 12; 62(17):8062-8079. PubMed ID: 31386368 [Abstract] [Full Text] [Related]
11. Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants. Zhu M, Zhou H, Ma L, Dong B, Zhou J, Zhang G, Wang M, Wang J, Cen S, Wang Y. Eur J Med Chem; 2021 Aug 05; 220():113450. PubMed ID: 33906049 [Abstract] [Full Text] [Related]
12. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands. Ghosh AK, Takayama J, Kassekert LA, Ella-Menye JR, Yashchuk S, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H. Bioorg Med Chem Lett; 2015 Nov 01; 25(21):4903-4909. PubMed ID: 26096678 [Abstract] [Full Text] [Related]
17. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Oscarsson K, Lahmann M, Lindberg J, Kangasmetsä J, Unge T, Oscarson S, Hallberg A, Samuelsson B. Bioorg Med Chem; 2003 Mar 20; 11(6):1107-15. PubMed ID: 12614898 [Abstract] [Full Text] [Related]
18. Potent HIV-1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein-Ligand X-ray Structural Studies. Ghosh AK, Xia Z, Kovela S, Robinson WL, Johnson ME, Kneller DW, Wang YF, Aoki M, Takamatsu Y, Weber IT, Mitsuya H. ChemMedChem; 2019 Nov 06; 14(21):1863-1872. PubMed ID: 31549492 [Abstract] [Full Text] [Related]
19. Design and synthesis of a novel series of HIV-1 protease inhibitors. Takashiro E, Nakamura Y, Miyamoto S, Ozawa Y, Sugiyama A, Fujimoto K. Bioorg Med Chem; 1999 Sep 06; 7(9):2105-14. PubMed ID: 10530961 [Abstract] [Full Text] [Related]